Serum and knee synovial fluid matrix metalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late-stage osteoarthritis

Acta Orthopaedica et Traumatologica Turcica

Volumn 50, Issue 3, 2016, Pages 356-361

  Özler, Kenan ^a   Aktas, Erdem ^a   Atay, Çiğdem ^a   Yilmaz, Baris ^b   Arikan, Murat ^a   Güngör, Safak ^a  

^a Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital   (Turkey)

^b Fatih Sultan Mehmet Research and Education Hospital   (Turkey)

Author keywords

Knee osteoarthritis; Matrix metalloproteinase; TNF alpha

Indexed keywords

COLLAGENASE 3; MMP13 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

AGED; BLOOD; CHEMISTRY; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; KNEE REPLACEMENT; MALE; METABOLISM; MIDDLE AGED; SEROLOGY; SYNOVIAL FLUID;

AGED; ARTHROPLASTY, REPLACEMENT, KNEE; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 13; MIDDLE AGED; OSTEOARTHRITIS, KNEE; SEROLOGY; SYNOVIAL FLUID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84979030643     PISSN: 1017995X     EISSN: None     Source Type: Journal    
DOI: 10.3944/AOTT.2015.15.0115     Document Type: Article

References (32)

1. Atik OS. Is subchondral bone the crucial point for the pathogenesis and the treatment of osteoarthritis? Eklem Hastalik Cerrahisi 2014;25:1.
2. Martel-Pelletier J, Pelletier JP. Is osteoarthritis a disease involving only cartilage or other articular tissues? Eklem Hastalik Cerrahisi 2010;21:2-14.
3. Cooper C, Snow S, McAlindon TE, Kellingray S, Stuart B, Coggon D, et al. Risk factors for the incidence and progression of radiographic knee osteoarthritis. Arthritis Rheum 2000;43:995-1000.
4. Atik OS, Tokgöz N. Do periarticular dense bone islands cause cartilage destruction? Eklem Hastalik Cerrahisi 2013;24:39-40.
5. Tashman S, Collon D, Anderson K, Kolowich P, Anderst W. Abnormal rotational knee motion during running after anterior cruciate ligament reconstruction. Am J Sports Med 2004;32:975-83.
6. Nishimura A, Hasegawa M, Kato K, Yamada T, Uchida A, Sudo A. Risk factors for the incidence and progression of radiographic osteoarthritis of the knee among Japanese. Int Orthop 2011;35:839-43.
7. Malemud CJ, Islam N, Haqqi TM. Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells Tissues Organs 2003;174:34-48.
8. Miller RE, Miller RJ, Malfait AM. Osteoarthritis joint pain: the cytokine connection. Cytokine 2014;70:185-93.
9. MacFarlane RJ, Graham SM, Davies PS, Korres N, Tsouchnica H, Heliotis M, et al. Anti-inflammatory role and immunomodulation of mesenchymal stem cells in systemic joint diseases: potential for treatment. Expert Opin Ther Targets 2013;17:243-54.
10. Santangelo KS, Nuovo GJ, Bertone AL. In vivo reduction or blockade of interleukin-1ß in primary osteoarthritis influences expression of mediators implicated in pathogenesis. Osteoarthritis Cartilage 2012;20:1610-8.
11. Wang W, Kang W, Tang Q, Yao G, Chen Y, Cheng B, et al. Cilostazol prevents the degradation of collagen type II in human chondrocytes. Biochem Biophys Res Commun 2014;451:352-5.
12. Zhang X, Zhu Y, Chen X, Zhang Y, Zhang Y, Jia Y, et al. Baicalein ameliorates inflammatory-related apoptotic and catabolic phenotypes in human chondrocytes. Int Immunopharmacol 2014;21:301-8.
13. Tang P, Hung M-C, Klostergaard J. Human pro-tumor necrosis factor is a homotrimer. Biochemistry 1996;35:8216- 25.
14. Kriegler M, Perez C, DeFay K, Albert I, Lu SD. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 1988;53:45-53.
15. Olszewski MB, Groot AJ, Dastych J, Knol EF. TNF trafficking to human mast cell granules: mature chain-dependent endocytosis. J Immunol 2007;178:5701-9.
16. Alaaeddine N, Hilal G, Baddoura R, Antoniou J, Di Battista JA. CCL20 stimulates proinflammatory mediator synthesis in human fibroblast-like synoviocytes through a MAP kinase-dependent process with transcriptional and posttranscriptional control. J Rheumatol 2011;38:1858- 65.
17. Alaaeddine N, Di Battista JA, Pelletier JP, Kiansa K, Cloutier JM, Martel-Pelletier J. Differential effects of IL- 8, LIF (pro-inflammatory) and IL-11 (anti-inflammatory) on TNF-alpha-induced PGE(2)release and on signalling pathways in human OA synovial fibroblasts. Cytokine 1999;11:1020-30.
18. Hermann J, Lipp RW, Dunzinger A, Spreizer C, Schaffler G, Kvaternik H, et al. Anti-TNF scintigraphy to assess TNF-α-associated joint inflammation in rheumatoid arthritis and osteoarthritis. Clin Exp Rheumatol 2014;32:614.
19. Quintana JM, Escobar A, Arostegui I, Bilbao A, Azkarate J, Goenaga JI, et al. Health-related quality of life and appropriateness of knee or hip joint replacement. Arch Intern Med 2006;166:220-6.
20. Loeuille D, Chary-Valckenaere I, Champigneulle J, Rat AC, Toussaint F, Pinzano-Watrin A. Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: correlating magnetic resonance imaging findings with disease severity. Arthritis and rheumatism 2005;52:3492-501.
21. Wassilew GI, Lehnigk U, Duda GN, Taylor WR, Matziolis G, Dynybil C. The expression of proinflammatory cytokines and matrix metalloproteinases in the synovial membranes of patients with osteoarthritis compared with traumatic knee disorders. Arthroscopy 2010;26:1096-104.
22. Bondeson J, Wainwright SD, Lauder S, Amos N, Hughes CE. The role of synovial macrophages and macrophageproduced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res Ther 2006;8:187.
23. Haack M, Pollmacher T, Mullington JM. Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers. Brain Behav Immun 2004;18:361-7.
24. Payette C, Blackburn P, Lamarche B, Tremblay A, Bergeron J, Lemieux I, et al. Sex differences in postprandial plasma tumor necrosis factor-alpha, interleukin-6, and C-reactive protein concentrations. Metabolism 2009;58:1593-601.
25. Zhou X. Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research. Curr Opin Clin Nutr Metab Care 2010;13:541-7.
26. Benito MJ, Veale DJ, FitzGerald O, Van den Berg WB, Bresnihan B. Synovial tissue inflammation in early and late osteoarthritis. Annals of the rheumatic diseases 2005;64:1263-7.
27. Aktas E, Sener E, Gocun PU. Mechanically induced experimental knee osteoarthritis benefits from anti-inflammatory and immunomodulatory properties of simvastatin via inhibition of matrix metalloproteinase-3. Orthopaedics and Traumatology 2011;12:145-51.
28. Yang Q, Wu S, Mao X, Wang W, Tai H. Inhibition effect of curcumin on TNF-alpha and MMP-13 expression induced by advanced glycation end products in chondrocytes. Pharmacology 2013;91:77-85.
29. Park SJ, Cheon EJ, Lee MH, Kim HA. MicroRNA-127-5p regulates matrix metalloproteinase 13 expression and interleukin- 1beta-induced catabolic effects in human chondrocytes. Arthritis and rheumatism 2013;65:3141-52.
30. Kobayashi M, Squires GR, Mousa A, Tanzer M, Zukor DJ, Antoniou J, et al. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis and Rheumatism 2005;52:128-35.
31. Ryu JH, Lee A, Na JH, Lee S, Ahn HJ, Park JW, et al. Optimization of matrix metalloproteinase fluorogenic probes for osteoarthritis imaging. Amino Acids 2011;41:1113- 22.
32. Rutgers M, Saris DB, Dhert WJ, Creemers LB. Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection. Arthritis research & therapy 2010;12:114.